Top Banner
Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures by X-ray diffraction of crystals 2. Development of user-friendly computers 3. Their convergence to DRUG DESIGN
42

Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Jan 18, 2016

Download

Documents

Tamsyn Osborne
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Milestones in Crystallography and Drug Design

Jenny P. GluskerFox Chase Cancer CenterPhiladelphia, PA 19111 USA

1. Determination of molecular structures by X-ray diffraction of crystals

2. Development of user-friendly computers

3. Their convergence to DRUG DESIGN

Page 2: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Seeing moleculesElectron microscopy X-ray diffraction of crystals

Page 3: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Early milestones in structure analysis

1. Discovery of X rays1895 Wilhelm Conrad RöntgenNobel Prize (physics) 1901Nature 53, 274 (1896)

2. Diffraction of X rays1912 Max Theodor Felix von LaueNobel Prize (physics) 1914Sitzungsber. Bayer. Akad. Wiss. Munchen p. 303 (1912)

3. Structure determination1913 William Henry Bragg & William Lawrence BraggNobel Prize (physics) 1915Proc. Roy. Soc. A89, 248 (1913)

Page 4: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Early X-ray photograph(Röntgen, 1895)

1895

Page 5: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Diffraction by a sieve anda crystalline virus

tobacco necrosis virus crystalcourtesy R.W.G. Wyckoff

photograph of a point sourceof light taken through a sieve

1958

Page 6: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

The first X-ray diffraction photographs of crystals

(Friedrich and Knipping, 1912)

1912

Page 7: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Apparatus for X-ray diffraction

detectionsystem

crystal

source ofX rays

Page 8: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Sodium chloride structure

W. L. Bragg. Proc. Roy. Soc. A89, 248 (1913)

1913

Page 9: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Sodium and potassium chlorides

KCl

NaCl

KCl has larger unit cell than NaCl, therefore diffraction lines are closer for KCl

1913

Page 10: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Electron-density maps and phases

Page 11: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Information from X-ray diffraction

1. Angles of diffracted beams give the unit-cell dimensions

2. Orders of diffraction (h,k,l) give the periodicities of the electron-density waves

3. Intensities of diffracted beams give amplitudesof electron-density waves and can lead toatomic positions if the PHASE PROBLEMcan be solved

Page 12: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

1930

Page 13: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Patterson functionpotassium dihydrogen phosphate

1930

Page 14: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

19311931

Page 15: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

1931

Page 16: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

1934

Page 17: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

1936

Page 18: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

1930

Page 19: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Steroid structure (Bernal)

Wieland and Windaus formulae

Bernal, RosenheimKing formula

Wieland, Daneformula(also crystal structure)

HO

1932

Page 20: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Absolute configuration J.M. Bijvoet Nature 168, 271 (1951)

1951

Page 21: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Absolute configurationJ. M. Bijvoet

1951

Page 22: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Penicillin chemical formula

S

N

HOOCCH3

CH3

O

NH

CH2Ph

O

H

H

S

HN

HOOC

CH3

CH3

N

O

O

CH2Ph

H

H

1949

-lactam oxazolone

Page 23: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Penicillin

Penicillin G in penicillin acylase 1FXV Protein Eng. 13, 857 (2000) and1GM7 J. Mol. Biol. 313, 139 (2001)

Page 24: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Morphine

HO

O

HO

H

N

CH3

morphine

MORPHI Mackay & Hodgkin J.Chem. Soc. 3261 (1955)MORPHM Bye Acta Chem. Scand. B30, 549 (1976)

1955

Page 25: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Computing of the time

Cambridge EDSAC 2Computer 1960

1960

Cosine function,Beevers-Lipson strip and IBMpunched card

Patterson projection of whalemyoglobin

Page 26: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Direct methods

Page 27: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Electron-density maps and phases

Page 28: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Hexamethylbenzene

K. Lonsdale. Nature 122, 810 (1928)

h k l7 -3 0 3 4 04 -7 0 intense(triplet)

1928

Page 29: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Vitamin B12 coenzyme structure

Hodgkin. Nature 176, 325 (1955),

Page 30: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Vitamin B12 coenzyme

1955

Hodgkin. Nature 176, 325 (1955), Proc. Roy. Soc. A303, 45 (1968)

Page 31: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

B DNA fibers

1953

Page 32: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Myoglobin

Kendrew and co-workers Nature 185, 422 (1960)

1960

Page 33: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Cytochrome P450

1985

Biochem. 26,8165 (1987)

Page 34: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Lysozyme with polysaccharide

1966

Sci. Amer. 215, 75 (1966)

Page 35: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Dihydrofolate reductase

A substrate analoguedoes not always bindin the same way as the substrate

1977

Science 197, 452 (1977)

Page 36: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Transition states

Linus Pauling, C&E News 24, 1375 (1946)

A enzyme lowers the energy barriers of a reaction by preferentially stabilizing the transition state of the substrate during the reaction rather than the ground state of that substrate

1946

Page 37: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Intermolecular interactions

Rosenfield JACS 99 4860 (1977)

1977

Page 38: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Intermolecular interactions

Murray-RustJACS 106, 1018 (1984)

1984

Page 39: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

DNA interactions

SeemanPNAS 73, 804 (1976)

1976

Page 40: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Following reactionsBurgi, Dunitz, Shefter

Burgi, DunitzShefter JACS 95, 5065 (1973)

1973

Page 41: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Following reactionsLaue method

(Nature 329, 178 (1987)

1

3 4

2

1987

Page 42: Milestones in Crystallography and Drug Design Jenny P. Glusker Fox Chase Cancer Center Philadelphia, PA 19111 USA 1. Determination of molecular structures.

Homology modeling -secretaseWild-type beta secretase Swedish mutant

(better substrate)

Dunbrack, J. Mol. Biol. 300, 241 (2000)

2000